Harte Hanks (HHS) Liabilities and Shareholders Equity (2016 - 2025)
Harte Hanks has reported Liabilities and Shareholders Equity over the past 16 years, most recently at $91.8 million for Q4 2025.
- Quarterly Liabilities and Shareholders Equity fell 9.78% to $91.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $380.1 million through Dec 2025, down 12.23% year-over-year, with the annual reading at $91.8 million for FY2025, 9.78% down from the prior year.
- Liabilities and Shareholders Equity was $91.8 million for Q4 2025 at Harte Hanks, down from $92.7 million in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $122.8 million in Q4 2023 and troughed at $91.8 million in Q4 2025.
- The 5-year median for Liabilities and Shareholders Equity is $111.1 million (2022), against an average of $109.2 million.
- Year-over-year, Liabilities and Shareholders Equity rose 11.24% in 2022 and then decreased 17.09% in 2024.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $107.9 million in 2021, then increased by 11.24% to $120.0 million in 2022, then increased by 2.31% to $122.8 million in 2023, then decreased by 17.09% to $101.8 million in 2024, then fell by 9.78% to $91.8 million in 2025.
- Per Business Quant, the three most recent readings for HHS's Liabilities and Shareholders Equity are $91.8 million (Q4 2025), $92.7 million (Q3 2025), and $95.0 million (Q2 2025).